Search results
This Nobel Prize-winning scientist breaks down the future of RNA and CRISPR technology | CNN
CNN.com· 10 hours agoWhile you’re probably pretty familiar with DNA, it’s likely that RNA only made it onto your radar...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 1 day agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
...Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD...
Benzinga· 7 days agoOn Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 2 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
WSAU Wausau· 9 hours ago(Reuters) - COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots...
US approves Moderna’s RSV vaccine for older adults | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 5 days agoThe US Food and Drug Administration on Friday approved Moderna’s respiratory syncytial virus (RSV)...
‘Out of control’: Why the discovery of H5N1 bird flu in mice is so alarming
The Telegraph via Yahoo News· 7 hours agoHouse mice have become the latest mammal to become infected with H5N1 bird flu, sparking fears that...
US nears deal to fund Moderna’s bird flu vaccine trial, FT reports
WHTC 1450 Holland· 7 days ago(Reuters) - The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA...
US approves Moderna’s RSV vaccine for older adults | FOX 28 Spokane
FOX 28 Spokane· 5 days agoThe US Food and Drug Administration on Friday approved Moderna’s respiratory syncytial virus (RSV)...
S&P 500, Nasdaq 100 Jointly Hit All-Time Highs, Nvidia Overtakes Apple As Second Most Valuable US...
Benzinga via Yahoo Finance· 3 hours agoThe U.S. stock market’s Wednesday session is a historic one, as both the S&P 500 and the Nasdaq 100...